Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545241 - 545260 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 70MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 80MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 80MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB TARTRATE 150MG CAP,ORAL | 4X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CiplaUSA,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB TARTRATE 150MG CAP,ORAL | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB TARTRATE 200MG CAP,ORAL | 4X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CiplaUSA,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB TARTRATE 200MG CAP,ORAL | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB TARTRATE 50MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CiplaUSA,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB TARTRATE 50MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 150MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 150MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 200MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 200MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 50MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 50MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB 71MG TAB,PACK,28 | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB 71MG TAB,PACK,28 | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L01EA03) nilotinib (adm: O) | NILOTINIB 95MG TAB,PACK,28 | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
Pages
